Back

SGLT2 inhibitors in acute myocardial infarction: what can we learn from the DAPA-MI trial? More news from American Heart Association Scientific Meeting

European Heart Journal - Cardiovascular Pharmacotherapy

7 December 2023
Organised by: Logo
Read full article
ESC Journals

Contributors

Eri Toda Kato
Eri Toda Kato

Author

Kyoto University Hospital Kyoto , Japan

Koh Ono
Koh Ono

Author

Basil S Lewis
Basil S Lewis

Author

You may be interested in
thumbnail
Congress Presentation
Efficacy and safety of dapagliflozin in non-diabetic patients with anterior wall ST-segment elevation acute myocardial infarction
15 March 2025
thumbnail
Congress Session
Treatment of cardiovascular comorbidities in patients with heart failure
17 May 2025
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Presentation
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry
26 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources